DISCOUNT ZERTIFIKAT - BIOGEN IDEC | Market Closed - Boerse Frankfurt Warrants 13:54:49 2024-06-07 EDT | ||
| 151.6 EUR | +0.51% |
|
| Current month | +0.71% | ||
| 1 month | +0.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 151.6 | +0.51% |
| 24-06-06 | 150.8 | -0.15% |
| 24-06-05 | 151.1 | +0.40% |
| 24-06-04 | 150.5 | +0.28% |
| 24-06-03 | 150 | -0.33% |
Real-time Boerse Frankfurt Warrants
Last update June 07, 2024 at 01:54 pm
More quotesStatic data
| Product type | Discount-Zertifikate |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VD39RG |
| ISIN | DE000VD39RG4 |
| Date issued | 2024-04-18 |
| Maturity | 2024-12-20 (195 Days) |
| Parity | 1 : 1 |
| Emission price | 148.4 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 151.7 € |
|---|---|
| Lowest since issue | 146.3 € |
| Spread | 0.21 € |
| Spread % | 0.14% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
225.4
USD
Average target price
284.6
USD
Spread / Average Target
+26.26%
- Stock Market
- Certificates
- Certificat
